Two Seas Capital LP Roivant Sciences Ltd. Transaction History
Two Seas Capital LP
- $611 Million
- Q4 2024
A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 10,167,807 shares of ROIV stock, worth $109 Million. This represents 19.7% of its overall portfolio holdings.
Number of Shares
10,167,807
Previous 10,167,807
-0.0%
Holding current value
$109 Million
Previous $120 Million
-0.0%
% of portfolio
19.7%
Previous 19.7%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$703 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$663 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$511 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...